PROGRAM

PRELIMINARY PROGRAM

23th October

9.00-9.45 Registration, Opening

9.45-10.15 Plenary lecture: Treatment of gastric cancer-present state and perspectives. Ivan Stilidi (Russia)

10.15-10.45 Plenary lecture: Basics of immunotherapy recent developments. Christoph Zielinski (Austria)

COURSE A. ESOPHAGEAL & GASTRIC CANCER | ROOM 1 COURSE B. ОNCOGYNECOLOGY | ROOM 2 COURSE C. LUNG CANCER | ROOM 3

11.00-13.30 

Session A1. Surgical treatment of Esophageal and Gastric cancer

  • Staging and classification of gastric and esophago-gastric junction cancer. Michail Ter-Ovanesov (Russia)
  • Surgical treatment of patients with cancer of the esophagus and cardia. Pavel Kononets (Russia)
  • Surgical treatment of patients with gastric cancer. Alexey Kalinin (Russia)
  • Laparoscopic surgery for early gastric cancer. Maxim Nikulin (Russia)
  • Laparoscopic surgery of locally advanced gastric cancer. Igor Khatkov, Roman Izrailov (Russia)
  • Surgical removal of primary tumor in patients with primary metastatic gastric cancer: yes/ no. Sergey Nered (Russia)
  • Perioperative chemo (radio) therapy versus primary surgery for adenocarcinoma of the stomach, gastro-esophageal junction and lower esophagus. Sebastian Schoppmann (Austria)

14.30-16.30 

Session A2. Epidemiology and Prevention

  • Esophageal cancer: epidemiology and prevention. Eva Negri (Italy)
  • Gastric cancer: epidemiology and prevention. Carlo La Vecchia (Italia)
  • Early endoscopic diagnosis and treatment of gastric cancer. Olga Malichova (Russia)
  • Hereditary esophageal and gastric cancer. Ludmila Lubchenko (Russia)

11.00-13.30 

Session B1. Epidemiology and Prevention

  • HPV vaccination is effective: lost opportunities and consequences for Russia. David Zaridze (Russia) 
  • National programs of HPV vaccination: implementation and results. Xavier Bosch (Spain)
  • HPV-FASTER. Vaccinating adult women. Joakim Dillner (Sweden)
  • Projection of cervical cancer incidence in the cohorts of vaccination and not vaccinated Russian women. vaccination and not vaccinated Russian women. Iacopo Baussano (IARC, France)    
  • PV based screening strategies. New triage approaches for HPV-positive women.  Maribel Almonte (IARC, France) 
  • The causes of failure in cytological screening for cervical cancer. Preinvasive disease.  Lubov Korolenkova (Russia)
  • Genetic susceptibility to ovarian cancer. Eugeniy Imyanitov (Russia)

14.30-16.50

Session B2. Cervical cancer

  • Mechanism of HPV Carcinogenesis. Svetlana Vinokurova (Russia)
  • Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.  Heinz Kölbl (Austria)
  • The Organ saving treatment of cervical cancer.  Аlexey Shevchuk (Russia)
  • Systemic treatment of cervical cancer (early and advanced). Elena Artamonova (Russia)
  • Immunotherapy of cervical cancer. Elena Artamonova (Russia)
  • Cervical cancer and pregnancy.  Lubov Korolenkova (Russia)
  • HPV  vaccination of  patients after primary treatment of  HPV associated cervical precancerous lesions and cancer. Olga Trushinа (Russia)  

11.00-13.30

Session C1. Epidemiology, prevention and molecular characteristics

  • Epidemiology and primary prevention of lung cancer
  • Smoking cessation after diagnosis of cancer
  • Screening for lung cancer
  • Genomic classification of lung cancer
  • Molecular characteristics of SCLC and neuro-endocrine lung tumours: the impact on their clinical management

14.30-15.30

Session С2. Imaging diagnostics

  • Imaging modalities
  • Image-guided intervention diagnosis
  • Optimal sequence of therapy NSCLC EGFRm

15.30-16.50

Session С3. Immunotherapy of NSCLC

  • Immune Checkpoint Inhibition: Rationale and Treatment of Stage IV NSCLC
  • Immunotherapy of stage III NSCLC
  • Immune Checkpoint Inhibition in Treatment of NSCLC: Overview
  • Immune Checkpoint Inhibition in SCLC
  • Immunotherapy in NSCLC clinical guidelines: yesterday, today, tomorrow

 

 

 

 

24th October

9.00-9.30 Registration

COURSE A. ESOPHAGEAL & GASTRIC CANCER | ROOM 1 COURSE B. ОNCOGYNECOLOGY | ROOM 2 COURSE C. LUNG CANCER | ROOM 3

9.30-11.30 

Session A3. Medical Treatment of Esophageal & Gastric cancer

  • Standard chemotherapy plus / minus VEGF inhibitors. Speaker not yet confirmed
  • New HER inhibitors. Christoph Zielinski (Austria)
  • Immune check point inhibitors.  Christoph Zielinski (Austria)
  • Personalized medical treatment of patients with primary disseminated gastric cancer.  Natalia Besova (Russia)
  • Radiotherapy (brachytherapy) for cancer of the esophagus. Irina Gladilina (Russia) 
  • Radiotherapy (brachytherapy) for gastric cancer.  Speaker not yet confirmed

9.30-11.50

Session B3. Cancer of the vulva and vagina, сancer of the ovary

  • Cancer of the vulva and vagina - Diagnostic assessment, staging, surgical treatment and adjuvant radiotherapy. Elena Ulrikh (Russia)
  • Classification. Subtypes. Primary site assignment. Kirill Zhordaniа (Russia)
  • Surgery: Primary and interval debulking surgery. Heinz Kölbl (Austria)
  • Standard therapy. Targeted therapy plus minus VEGF inhibitors. Immunotherapy?  Alexandra Tulyandina (Russia)
  • Management of BRCA mutation associated ovarian cancer. Andrey Mechsheryakov (Russia)
  • anagement of recurrent disease. Debulking surgery: pro/contra? Systemic treatment.  Alexey Schevchuk (Russia)
  • Management of brain metastasis of ovarian cancer.  David Nashletashvili (Russia)

    13.00-14.00

Session B5. Endometrial cancer

  • Surgical treatment: Minimally invasive surgery, total hysterectomy with bilateral salpingo-oophorectomy with or without removal of pelvic and para-aortic lymph nodes. Heinz Kölbl (Austria)
  • Current status of brachytherapy in oncogynecology - modern principles, concepts, clinical results. Olga Kravets (Russia)
  • Malignant trophoblastic disease. Ludmila Meshcheryakova (Russia)

9.30-11.30

Session С4. Targeted therapy

  • Treatment of EGFR positive NSCLC
  • Treatment of ALK positive NSCLC
  • Systematic therapy of advanced driver mutation-negative NSCLC
  • Management of brain metastases in advanced driver mutation-positive NSCLC

13.00-14.00

Session С5. Surgical treatment

  • Open surgery for early stage NSCLC
  • Video-Assisted Thoracoscopic Surgery (VATS)
  • Interventional bronchoscopy for the management of early lung cancer

14.00-14.40

Session С6Radiotherapy

  • Radiofrequency Ablation (RFA)
  • Stereotactic body radiotherapy

 

 

back to top